Parque Científico Universidad de Valencia, Catedrático Agustin Escardino, 9, 46980, Paterna, Valencia
info@sabartech.com
CASSANDRA
Lung cancer screening
Lung cancer continues to be the most lethal cancer in Spain. This is largely due to the advanced stage in which more than 70% of patients are at the time of diagnosis.
Despite its proven efficacy, Spain does not yet have a unified lung cancer screening protocol. The aim of the CASSANDRA project is to initiate a national screening program that can join forces with existing smoking cessation programs in Spain, which have proven to be insufficient in reducing the number of people affected by lung cancer.
The CASSANDRA project (Cancer Screening, Smoking Cessation, AND Respiratory Assessment) is a project led by SEPAR whose main coordinators are Dr. Luis Seijo, a pulmonologist at the Clínica Universitaria de Navarra, and Dr. Juan Carlos Trujillo-Reyes, a thoracic surgeon at the Hospital de la Santa Creu I Sant Pau and Coordinator of the Thoracic Oncology Area, in addition to the collaboration of a large number of professionals with expertise in lung cancer screening.
Parque Científico Universidad de Valencia, Catedrático Agustin Escardino, 9, 46980, Paterna, Valencia
info@sabartech.com
EXPEDIENT Nº: IMIDTA/2023/43.
PROGRAM: SME R&D PROJECTS (PIDI-CV) 2023
PROJECT: AIG-SPORT – THE NEXT GENERATION OF SPORT PERFORMANCE (AIG-SPORT)
OBJECTIVES: The generation of a new model of 5P SPORTS TECHNOLOGY to revolutionise professional and amateur sport.
RESULTS ACHIEVED: A software focused on sports performance called AIG-SPORT that aims to bring science closer to athletes through guidelines for the improvement of sports performance, athletes’ brands, the prevention of injuries related to exercise and training, the personalisation of food and supplementation plans in a much more precise way.
THIS PROJECT IS SUPPORTED BY THE EUROPEAN UNION AS IT HAS BEEN SELECTED IN THE FEDER OPERATIONAL PROGRAMME FOR THE VALENCIAN COMMUNITY 2021-2027.
Expedient Nº: INNEST/2021/292
Project: INTELLIGENT PLATFORM FOR EARLY DETECTION, DIAGNOSIS AND MONITORING OF SARCOPENIA (iSARC-GENETICS)
Supported by Agència Valenciana de la Innovació (AVI)
